Back to Search
WILLIAM PLUNKETT, MD
MD
Internal Medicine Physician
NPI: 1871553016IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
2006-00034(NC)MD.07053R(LA)
CMS Specialties
PrimaryINTERNAL MEDICINE
Education
EASTERN VIRGINIA MEDICAL SCHOOL
Class of 1983
Research & Publications (20)
Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer.
PMID 19460966·Science·2009
7-preclinical
Specific activation of microRNA106b enables the p73 apoptotic response in chronic lymphocytic leukemia by targeting the ubiquitin ligase Itch for degradation.
PMID 19096009·Blood·2009
8-other
PROMISE: a tool to identify genomic features with a specific biologically interesting pattern of associations with multiple endpoint variables.
PMID 19528086·Bioinformatics·2009
8-other
Targeting DNA repair in chronic lymphocytic leukemia cells with a novel acyclic nucleotide analogue, GS-9219.
PMID 19435836·Clin Cancer Res·2009
8-other
Mechanism of action of SNS-032, a novel cyclin-dependent kinase inhibitor, in chronic lymphocytic leukemia.
PMID 19234140·Blood·2009
8-other
Ataxia-telangiectasia and Rad3-related and DNA-dependent protein kinase cooperate in G2 checkpoint activation by the DNA strand-breaking nucleoside analogue 2'-C-cyano-2'-deoxy-1-beta-D-arabino-pentofuranosylcytosine.
PMID 18202016·Mol Cancer Ther·2008
8-other
Polyadenylation inhibition by the triphosphates of deoxyadenosine analogues.
PMID 18433867·Leuk Res·2008
8-other
Treatment of core-binding-factor in acute myelogenous leukemia with fludarabine, cytarabine, and granulocyte colony-stimulating factor results in improved event-free survival.
PMID 18932257·Cancer·2008
3-trial
GS-9219--a novel acyclic nucleotide analogue with potent antineoplastic activity in dogs with spontaneous non-Hodgkin's lymphoma.
PMID 18451250·Clin Cancer Res·2008
7-preclinical
Repair of 2'-C-cyano-2'-deoxy-1-beta-D-arabino-pentofuranosylcytosine-induced DNA single-strand breaks by transcription-coupled nucleotide excision repair.
PMID 18483273·Cancer Res·2008
7-preclinical
Effective elimination of fludarabine-resistant CLL cells by PEITC through a redox-mediated mechanism.
PMID 18574029·Blood·2008
8-other
Phase I-II study of oxaliplatin, fludarabine, cytarabine, and rituximab combination therapy in patients with Richter's syndrome or fludarabine-refractory chronic lymphocytic leukemia.
PMID 18182662·J Clin Oncol·2008
3-trial
ATM and the Mre11-Rad50-Nbs1 complex respond to nucleoside analogue-induced stalled replication forks and contribute to drug resistance.
PMID 18829552·Cancer Res·2008
7-preclinical
H2AX phosphorylation marks gemcitabine-induced stalled replication forks and their collapse upon S-phase checkpoint abrogation.
PMID 17406032·Mol Cancer Ther·2007
8-other
Inhibition of topoisomerase IIalpha and G2 cell cycle arrest by NK314, a novel benzo[c]phenanthridine currently in clinical trials.
PMID 17513599·Mol Cancer Ther·2007
8-other
The role of DNA repair in chronic lymphocytic leukemia pathogenesis and chemotherapy resistance.
PMID 17706164·Curr Oncol Rep·2007
6-review
Pharmacogenetics of deoxycytidine kinase: identification and characterization of novel genetic variants.
PMID 17855478·J Pharmacol Exp Ther·2007
8-other
miRNAs and their potential for use against cancer and other diseases.
PMID 17927518·Future Oncol·2007
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 15813 PAUL VEGA MD DR STE 300
HAMMOND, LA 70403 - Phone
- (985) 230-7675
Quick Facts
- NPI
- 1871553016
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 43
- Publications
- 20
Are you this provider?
Claim Your Profile